These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

427 related items for PubMed ID: 8404615

  • 1. Retinoic acid potentiates phorbol ester-mediated induction of urokinase and plasminogen activator inhibitor type 2 in human myeloid leukemic cell lines.
    Schuster WA, Medcalf RL, Kruithof EK.
    Endocrinology; 1993 Oct; 133(4):1724-30. PubMed ID: 8404615
    [Abstract] [Full Text] [Related]

  • 2. Modulation of urokinase-type plasminogen activator and plasminogen activator inhibitor-2 expression by U-937 mononuclear phagocytes. Effects of 1 alpha, 25-dihydroxyvitamin D3 and phorbol ester.
    Gyetko MR, Webb AC, Sitrin RG.
    J Immunol; 1988 Oct 15; 141(8):2693-8. PubMed ID: 3139763
    [Abstract] [Full Text] [Related]

  • 3. The THP-1 cell line is a urokinase-secreting mononuclear phagocyte with a novel defect in the production of plasminogen activator inhibitor-2.
    Gross TJ, Sitrin RG.
    J Immunol; 1990 Mar 01; 144(5):1873-9. PubMed ID: 2307845
    [Abstract] [Full Text] [Related]

  • 4. Down-regulation of proteolytic activity in 12-O-tetradecanoyl-phorbol-13-acetate-induced K562 leukemia cell cultures: depletion of active urokinase by excess type 1 plasminogen activator inhibitor.
    Alitalo R, Andersson LC, Tapiovaara H, Sistonen L, Vaheri A, Stephens R.
    J Cell Physiol; 1989 Jul 01; 140(1):119-30. PubMed ID: 2500450
    [Abstract] [Full Text] [Related]

  • 5. Urokinase-mediated transactivation of the plasminogen activator inhibitor type 2 (PAI-2) gene promoter in HT-1080 cells utilises AP-1 binding sites and potentiates phorbol ester-mediated induction of endogenous PAI-2 mRNA.
    Dear AE, Costa M, Medcalf RL.
    FEBS Lett; 1997 Feb 03; 402(2-3):265-72. PubMed ID: 9037208
    [Abstract] [Full Text] [Related]

  • 6. Different regulation of plasminogen activator inhibitor 2 gene expression by phorbol ester and cAMP in human myeloid leukemia cell line PL-21.
    Niiya K, Taniguchi T, Shinbo M, Ishikawa T, Tazawa S, Hayakawa Y, Sakuragawa N.
    Thromb Haemost; 1994 Jul 03; 72(1):92-7. PubMed ID: 7974383
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Retinoic acid upregulates the plasminogen activator system in human epidermal keratinocytes.
    Braungart E, Magdolen V, Degitz K.
    J Invest Dermatol; 2001 May 03; 116(5):778-84. PubMed ID: 11348470
    [Abstract] [Full Text] [Related]

  • 9. Difference in expression of the plasminogen activation system in synovial tissue of patients with rheumatoid arthritis and osteoarthritis.
    Ronday HK, Smits HH, Van Muijen GN, Pruszczynski MS, Dolhain RJ, Van Langelaan EJ, Breedveld FC, Verheijen JH.
    Br J Rheumatol; 1996 May 03; 35(5):416-23. PubMed ID: 8646430
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Differential expression of urokinase-type plasminogen activator, its receptor, and inhibitors in mouse skin after exposure to a tumor-promoting phorbol ester.
    Lund LR, Eriksen J, Ralfkiaer E, Rømer J.
    J Invest Dermatol; 1996 Apr 03; 106(4):622-30. PubMed ID: 8617995
    [Abstract] [Full Text] [Related]

  • 12. Expression of urokinase, plasminogen activator inhibitors and urokinase receptor in pregnant rhesus monkey uterus during early placentation.
    Feng Q, Liu Y, Liu K, Byrne S, Liu G, Wang X, Li Z, Ockleford CD.
    Placenta; 2000 Apr 03; 21(2-3):184-93. PubMed ID: 10736241
    [Abstract] [Full Text] [Related]

  • 13. Urokinase receptor mRNA level and gene transcription are strongly and rapidly increased by phorbol myristate acetate in human monocyte-like U937 cells.
    Lund LR, Rønne E, Roldan AL, Behrendt N, Rømer J, Blasi F, Danø K.
    J Biol Chem; 1991 Mar 15; 266(8):5177-81. PubMed ID: 1848242
    [Abstract] [Full Text] [Related]

  • 14. Induction of urokinase-type plasminogen activator receptor by IL-1 beta.
    Hasegawa T, Sorensen L, Dohi M, Rao NV, Hoidal JR, Marshall BC.
    Am J Respir Cell Mol Biol; 1997 Jun 15; 16(6):683-92. PubMed ID: 9191470
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Hyaluronic acid inhibits the expression of u-PA, PAI-1, and u-PAR in human synovial fibroblasts of osteoarthritis and rheumatoid arthritis.
    Nonaka T, Kikuchi H, Ikeda T, Okamoto Y, Hamanishi C, Tanaka S.
    J Rheumatol; 2000 Apr 15; 27(4):997-1004. PubMed ID: 10782829
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Raloxifene reduces urokinase-type plasminogen activator-dependent proliferation of synoviocytes from patients with rheumatoid arthritis.
    Guiducci S, Del Rosso A, Cinelli M, Perfetto F, Livi R, Rossi A, Gabrielli A, Giacomelli R, Iori N, Fibbi G, Del Rosso M, Cerinic MM.
    Arthritis Res Ther; 2005 Apr 15; 7(6):R1244-53. PubMed ID: 16277677
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-1beta regulates urokinase plasminogen activator (u-PA), u-PA receptor, soluble u-PA receptor, and plasminogen activator inhibitor-1 messenger ribonucleic acid expression in cultured human endometrial stromal cells.
    Chung HW, Wen Y, Ahn JJ, Moon HS, Polan ML.
    J Clin Endocrinol Metab; 2001 Mar 15; 86(3):1332-40. PubMed ID: 11238529
    [Abstract] [Full Text] [Related]

  • 20. [Effect of cyclic AMP and phorbol ester on PAI-2 synthesis in a leukemic cell line PL-21 and on u-PA secretion in a pre-B cell lymphoma cell line RC-K8].
    Niiya K, Sakuragawa N.
    Nihon Rinsho; 1992 Feb 15; 50(2):325-9. PubMed ID: 1319513
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.